Abstract

Abstract Owing to the moist and curved interfaces of skin wounds, enhancing the adhesiveness while maintaining delivery efficacy of biomolecules has drawn significant attention in advanced wound dressings. Despite tremendous trials to load biomolecules with sound adhesiveness, the complicated fabricating processes and abnormal allergic responses that are attributed to chemical moiety‐based adhesives remain as major problems. To this end, in this study a one‐step fabrication process is developed to manufacture microstructures with both a therapeutic (cylindrical structure for embossed structure human adipose‐derived stem cell sheet, ESS) and an adhesive part (octopi‐inspired structure of adhesive, OIA), which ESOIA is called. OIA showed the highest adhesion strength in both dry (1.48 N cm −2 ) and wet pig skin conditions (0.81 N cm −2 ), maintaining the adhesive properties after repeated attach–detach trials. ESS from the therapeutic part of ESOIA also showed an enhanced angiogenic effect compared with the ones that are normally cultured in vitro. ESS also showed improved in vivo wound healing outcomes following enhanced cell engraftment compared to the cell injection group by means of intact cell‐extracellular matrix interactions.